By Holly Alyssa MacCormick  A single infusion of a modified CAR-T cell therapy could pave the way for a potential one-shot cure for HIV, according to preliminary findings of a small, early-stage clinical trial. Steven G. Deeks, MD, the principal investigator of this California Institute for Regenerative Medicine (CIRM)-funded clinical trial, discussed the findings at a recent CIRM board meeting.  Steven Deeks, MD Photo: UCSF Roughly 40 million people worldwide and more … Continue reading Early trial shows promise for one‑shot cure for HIV